Publicação

Rituximab-induced hypersensitivity pneumonitis in a kidney transplant patient

Ver documento

Detalhes bibliográficos
Resumo:Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.
Autores principais:Silva,Natália
Outros Autores:Ribeiro,Catarina Isabel; Almeida,Manuela; Malheiro,Jorge; Pedroso,Sofia; Martins,Maria La Salete; Dias,Leonídio; Henriques,António Castro; Cabrita,António
Assunto:Drug-induced lung disease hypersensitivity pneumonitis kidney transplant rituximab
Ano:2020
País:Portugal
Tipo de documento:relatório
Tipo de acesso:acesso aberto
Instituição associada:Fundação para a Ciência e Tecnologia
Idioma:inglês
Origem:SciELO Portugal
Descrição
Resumo:Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.